CY1105208T1 - Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1 - Google Patents

Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1

Info

Publication number
CY1105208T1
CY1105208T1 CY20061100498T CY061100498T CY1105208T1 CY 1105208 T1 CY1105208 T1 CY 1105208T1 CY 20061100498 T CY20061100498 T CY 20061100498T CY 061100498 T CY061100498 T CY 061100498T CY 1105208 T1 CY1105208 T1 CY 1105208T1
Authority
CY
Cyprus
Prior art keywords
eteoparyl
receptor
derivatives
nociceptin
orl
Prior art date
Application number
CY20061100498T
Other languages
English (en)
Inventor
Deen Tulshian
Ginny D. Ho
Fay W. Ng
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of CY1105208T1 publication Critical patent/CY1105208T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Αποκαλύπτονται νέες ενώσεις του τύπου (I), όπου το R προαιρετικά είναι υποκατεστημένο ετεροαρύλ ή (α) το R1 είναι Η ή C1-C6 αλκύλ και τα R2 και R3 είναι -CH3, -OCH3 ή αλογόνο ή φαρμακευτικώς αποδεκτό άλας ή διαλύτωμα αυτών, φαρμακευτικές συνθέσεις αυτών και η χρήση των αναφερθεισών ενώσεων στη θεραπεία πόνου, άγχους, βήχα, άσθματος, κατάθλιψης και κατάχρησης αλκοόλ.
CY20061100498T 2001-11-07 2006-04-07 Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1 CY1105208T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33328401P 2001-11-07 2001-11-07
PCT/US2002/035539 WO2003039469A2 (en) 2001-11-07 2002-11-06 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1

Publications (1)

Publication Number Publication Date
CY1105208T1 true CY1105208T1 (el) 2010-03-03

Family

ID=23302135

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100498T CY1105208T1 (el) 2001-11-07 2006-04-07 Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1

Country Status (27)

Country Link
US (1) US6727254B2 (el)
EP (1) EP1442036B1 (el)
JP (2) JP4246066B2 (el)
KR (1) KR100596261B1 (el)
CN (1) CN1252068C (el)
AR (1) AR037211A1 (el)
AT (1) ATE315566T1 (el)
BR (1) BR0213907A (el)
CA (1) CA2465871C (el)
CY (1) CY1105208T1 (el)
DE (1) DE60208724T2 (el)
DK (1) DK1442036T3 (el)
EC (1) ECSP045096A (el)
ES (1) ES2256590T3 (el)
HK (1) HK1063019A1 (el)
HU (1) HUP0402329A2 (el)
IL (2) IL161120A0 (el)
MX (1) MXPA04004276A (el)
MY (1) MY126268A (el)
NO (1) NO329026B1 (el)
NZ (1) NZ532088A (el)
PE (1) PE20030719A1 (el)
PL (1) PL370269A1 (el)
RU (1) RU2327698C2 (el)
TW (1) TWI317360B (el)
WO (1) WO2003039469A2 (el)
ZA (1) ZA200403404B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
EP1567497B1 (en) 2002-12-06 2009-09-23 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
WO2005089761A1 (en) * 2004-03-17 2005-09-29 Pfizer Limited Combination for treating inflammatory diseases
CN100577661C (zh) * 2004-09-15 2010-01-06 先灵-普劳有限公司 取代的8-氮杂双环[3.2.1]辛-3-醇的制备方法
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
PE20071159A1 (es) * 2005-10-31 2007-11-30 Schering Corp Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
DK2324013T6 (en) * 2008-07-21 2014-12-15 Purdue Pharma Lp Substituted bridged piperidine compounds of quinoxalintype and uses thereof
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
GB201115853D0 (en) 2011-09-14 2011-10-26 Proximagen Ltd New enzyme inhibitor compounds
US9724340B2 (en) * 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
TW590268U (en) * 2000-08-08 2004-06-01 Wistron Corp Heat dissipating device

Also Published As

Publication number Publication date
IL161120A (en) 2010-11-30
JP2005508367A (ja) 2005-03-31
MY126268A (en) 2006-09-29
US6727254B2 (en) 2004-04-27
KR20050043725A (ko) 2005-05-11
MXPA04004276A (es) 2004-08-11
HUP0402329A2 (hu) 2005-02-28
JP4246066B2 (ja) 2009-04-02
CN1582288A (zh) 2005-02-16
TW200301765A (en) 2003-07-16
CA2465871A1 (en) 2003-05-15
RU2004117542A (ru) 2006-01-10
RU2327698C2 (ru) 2008-06-27
ATE315566T1 (de) 2006-02-15
NO329026B1 (no) 2010-08-02
BR0213907A (pt) 2004-09-28
ZA200403404B (en) 2005-08-15
WO2003039469A2 (en) 2003-05-15
ECSP045096A (es) 2004-06-28
WO2003039469A3 (en) 2003-10-16
DK1442036T3 (da) 2006-05-15
CN1252068C (zh) 2006-04-19
DE60208724D1 (de) 2006-04-06
NO20042294L (no) 2004-07-15
CA2465871C (en) 2009-01-20
PL370269A1 (en) 2005-05-16
TWI317360B (en) 2009-11-21
NZ532088A (en) 2006-05-26
JP2009035556A (ja) 2009-02-19
ES2256590T3 (es) 2006-07-16
EP1442036A2 (en) 2004-08-04
DE60208724T2 (de) 2006-11-02
PE20030719A1 (es) 2003-08-28
EP1442036B1 (en) 2006-01-11
IL161120A0 (en) 2004-08-31
HK1063019A1 (en) 2004-12-10
AR037211A1 (es) 2004-10-27
KR100596261B1 (ko) 2006-06-30
US20030119847A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
CY1105208T1 (el) Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1
DK1272477T3 (da) Pyrimidinforbindelser
CY1106087T1 (el) Παραγωγα τετραϋδροκινολινης
CY1111693T1 (el) Αντιιικοι παραγοντες
BRPI0209216B8 (pt) derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos
HUP0302480A2 (hu) Piridinonszármazékok ateroszklerózis kezelésére, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények
ATE450533T1 (de) Carboxamidderivate
HUP0400710A2 (hu) Tioéter helyettesítővel helyettesített imidazokinolinszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP0002461A2 (hu) Triciklusos benzotiepin- vagy benzoxepinszármazékok és ezeket tartalmazó gyógyszerkészítmények
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
WO2005080357A3 (fr) Derives d’oxazole, leur preparation et leur utilisation en therapeutique
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
CY1116183T1 (el) Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης
CY1105047T1 (el) Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
PE20030761A1 (es) Derivados del 7-amino-benzotiazol
NO20001402L (no) Substituerte kromanderivater
DK0992509T3 (da) Nye makrolid-derivater
DE60208178D1 (de) Chinolin-4-carboxamidderivate als nk-3 und nk-2 rezeptor antagonisten
KR920019746A (ko) 신규한 시클로헥실벤즈아미드 유도체, 그의 제조방법 및 약제로서의 용도
HUP0401883A2 (hu) Muszkarin agonisták és ezeket tartalmazó gyógyászati készítmények
CO5180624A1 (es) Antagonistas muscarinicos
DK0732332T3 (da) Substituerede benzothienylpiperaziner, deres anvendelse som lægemidler og fremgangsmåder til fremstilling deraf
SE0301371D0 (sv) New Compounds